GenMark Files for Public Offering of 4.6M Shares | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics has filed with the US Securities and Exchange Commission to offer 4.6 million shares of common stock.

The Carlsbad, Calif.-based molecular diagnostics developer filed its preliminary prospectus for the offering on Wednesday. It didn't say when it expects the offering to become effective.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.